These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23731523)

  • 21. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics.
    Merrick BA; London RE; Bushel PR; Grissom SF; Paules RS
    IARC Sci Publ; 2011; (163):121-42. PubMed ID: 22997859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi -omics and metabolic modelling pipelines: challenges and tools for systems microbiology.
    Fondi M; Liò P
    Microbiol Res; 2015 Feb; 171():52-64. PubMed ID: 25644953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of metabolomics in drug discovery and development.
    Wishart DS
    Drugs R D; 2008; 9(5):307-22. PubMed ID: 18721000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole genome data for omics-based research on the self-fertilizing fish Kryptolebias marmoratus.
    Rhee JS; Lee JS
    Mar Pollut Bull; 2014 Aug; 85(2):532-41. PubMed ID: 24759509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analysis of human omics data using biomolecular networks.
    Robinson JL; Nielsen J
    Mol Biosyst; 2016 Oct; 12(10):2953-64. PubMed ID: 27510223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicology Strategies for Drug Discovery: Present and Future.
    Blomme EA; Will Y
    Chem Res Toxicol; 2016 Apr; 29(4):473-504. PubMed ID: 26588328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omics data input for metabolic modeling.
    Rai A; Saito K
    Curr Opin Biotechnol; 2016 Feb; 37():127-134. PubMed ID: 26723010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic network modeling of microbial communities.
    Biggs MB; Medlock GL; Kolling GL; Papin JA
    Wiley Interdiscip Rev Syst Biol Med; 2015; 7(5):317-34. PubMed ID: 26109480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providing data science support for systems pharmacology and its implications to drug discovery.
    Hart T; Xie L
    Expert Opin Drug Discov; 2016; 11(3):241-56. PubMed ID: 26689499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-Wide Semi-Automated Annotation of Transporter Systems.
    Dias O; Gomes D; Vilaca P; Cardoso J; Rocha M; Ferreira EC; Rocha I
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(2):443-456. PubMed ID: 26887005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent advances in metabonomics].
    Xu GW; Lu X; Yang SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mixOmics: An R package for 'omics feature selection and multiple data integration.
    Rohart F; Gautier B; Singh A; Lê Cao KA
    PLoS Comput Biol; 2017 Nov; 13(11):e1005752. PubMed ID: 29099853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging applications of metabolomics in drug discovery and precision medicine.
    Wishart DS
    Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An omics perspective on drug target discovery platforms.
    Paananen J; Fortino V
    Brief Bioinform; 2020 Dec; 21(6):1937-1953. PubMed ID: 31774113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic network modeling and simulation for drug targeting and discovery.
    Kim HU; Sohn SB; Lee SY
    Biotechnol J; 2012 Mar; 7(3):330-42. PubMed ID: 22125297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foodomics as part of the host-microbiota-exposome interplay.
    Putignani L; Dallapiccola B
    J Proteomics; 2016 Sep; 147():3-20. PubMed ID: 27130534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.